[vc_row css=”.vc_custom_1591036811069{padding-top: 40px !important;background-position: 0 0 !important;background-repeat: no-repeat !important;}”][vc_column][vc_row_inner equal_height=”yes” content_placement=”middle” el_class=”container” css=”.vc_custom_1590782511055{padding-bottom: 60px !important;}”][vc_column_inner width=”1/6″][/vc_column_inner][vc_column_inner width=”2/3″][vc_video link=”https://vimeo.com/467804902/4923f36ea0″][vc_column_text css=”.vc_custom_1603898079755{margin-bottom: 20px !important;}” el_class=”presstitle”]

CMS Guidance ASCs and the Journey Ahead

[/vc_column_text][vc_column_text]

At the 2020 MedAxiom Transforum Marc Toth, VP of Cardiovascular Services at Atlas Healthcare Partners, presents perspectives on how added PCIs (Percutaneous Coronary Intervention) to the list of approved procedures for ASCs is a watershed moment in the outmigration of CV (cardiovascular) procedures. He discusses specific examples of how physicians and health systems can develop strategies for this important shift in cardiovascular services.

[/vc_column_text][vc_btn title=”BACK TO NEWSROOM” style=”outline-custom” outline_custom_color=”#d50032″ outline_custom_hover_background=”#d50032″ outline_custom_hover_text=”#ffffff” shape=”round” link=”url:https%3A%2F%2Fwww.atlashp.com%2Fnewsroom%2F|title:Newsroom”][/vc_column_inner][vc_column_inner width=”1/6″][/vc_column_inner][/vc_row_inner][/vc_column][/vc_row]